Loading, please wait...
:

product description page

Biomarkers in Cancer Screening and Early Detection - by Sudhir Srivastava (Hardcover)

Biomarkers in Cancer Screening and Early Detection -  by Sudhir Srivastava (Hardcover) - image 1 of 1

About this item

Biomarkers in Cancer Screening and Early Detection offers a comprehensive, state-of-the-art perspective on the various research and clinical aspects of cancer biomarkers, from their discovery and development to their validation, clinical utility, and clinical use. The primary purpose of this book is to summarize and present best practices in this field to date, and offer actionable information-and hopefully also inspiration-to move discovery and clinical application forward.

This latest volume of the Translational Oncology series, Biomarkers in Cancer Screening and Early Detection is organized into three sections: Section I lays the foundation for biomarker discovery, development and validation. Section II presents organ-specific topics relevant to the clinical needs in early detection, the natural history of the disease and associated evidence in support of biomarker research, an overview of the current state-of-the art in biomarker research, current progress toward bringing these biomarkers into clinical use and the future of biomarker-based screening and early detection for the respective organ type. Finally, Section III offers chapters that address the current screening strategies for selected organ types, discusses deficiencies with the present practice and identifies clinical needs that may benefit from biomarker-based approaches.

This latest volume of the Translational Oncology series, Biomarkers in Cancer Screening and Early Detection:

Provides immediately actionable information-and hopefully also inspiration-to move discovery and clinical application forward

Considers the cutting edge "bench to bedside and back" breakthroughs which have transformed the diagnosis, prognosis and treatment of cancer

Discusses screening guidelines, research strategies, and issues surrounding cancer overdiagnosis

Offers vital knowledge to help develop personalized cancer treatment for individual patients with specific cancers

The development of cancer is preceded by numerous mutations and changes which transform normal cells into benign tumors, and progressively into malignant and metastatic forms. This enormous complexity makes cancer detection, diagnosis, and treatment challenging and therefore the ability to identify tumors that are destined to progress at an early stage will allow effective treatment interventions and reduce deaths. This new book comprehensively summarises the current state of the field and is an ideal resource for clinical and research oncologists interested in the progress of screening and detection of cancer.

Sudhir Srivastava, Ph.D., MPH Senior Scientific Officer, Chief of the Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, graduate (MPH) of the John Hopkins University, and graduate (M.S.) of the Virginia Commonwealth University

Robert C. Bast, MD, Vice President for Translational Research, The University of Texas MD Anderson Can
Number of Pages: 304
Genre: Medical
Series Title: Translational Oncology
Format: Hardcover
Publisher: John Wiley & Sons Inc
Author: Sudhir Srivastava
Language: English
Street Date: August 28, 2017
TCIN: 51756969
UPC: 9781118468807
Item Number (DPCI): 248-31-9253
If the item details above aren’t accurate or complete, we want to know about it. Report incorrect product info.
$149.95
Shipping
not available
Not in stores

Guest reviews

Prices, promotions, styles and availability may vary by store & online. See our price match guarantee. See how a store is chosen for you.


*See offer details. Restrictions apply. Pricing, promotions and availability may vary by location and at Target.com.